ADVFN - Advanced Financial Network.
HOME» NYSE » V » VRX Stock Price » VRX Stock News

Valeant Pharma Share News

 Valeant Pharmaceuticals International Stock Price
VRX Stock Price
 Valeant Pharmaceuticals International Stock Chart
VRX Stock Chart
 Valeant Pharmaceuticals International Stock News
VRX Stock News
 Valeant Pharmaceuticals International Company Information
VRX Company Information
 Valeant Pharmaceuticals International Stock Trades
VRX Stock Trades

Sanofi Finalizes Sale Of Dermik To Valeant Pharmaceuticals

PARIS -(Dow Jones)- French drug company Sanofi-Aventis (SAN.FR) announced Monday the finalization of the sale of its Canadian dermatology business, Dermik, to Valeant Pharmaceuticals International Inc. (VRX) for $422.5 million. In a statement, Sanofi said the transaction includes an aesthetic and therapeutic business in the U.S. and Canada, as well as an aesthetic business around the world. Sanofi's Canadian unit will continue its operations in Greater Montreal, said the company. -By Nadya Masidlover, Dow Jones Newswires; +33 1 4017 1740; nadya.masidlover@dowjones.com

Stock News for Valeant Pharma (VRX)
DateTimeHeadline
08/24/201618:20:00Mylan Faces Scrutiny Over EpiPen Price Increases
08/24/201616:45:41Statement of Changes in Beneficial Ownership (4)
08/24/201616:34:17Initial Statement of Beneficial Ownership (3)
08/23/201617:03:35Current Report Filing (8-k)
08/23/201616:56:43Current Report Filing (8-k)
08/23/201603:03:00New CFO Tops Off Shake-Up At Valeant -- WSJ
08/23/201601:00:00Pharming Convene an Extraordinary General Meeting of Shareholders
08/23/201601:00:00Pharming Convene an Extraordinary General Meeting of Shareholders
08/22/201615:32:00Valeant Names Zoetis Executive as Financial Chief--Update
08/22/201615:30:00Valeant Names Zoetis Executive as Financial Chief--Update
08/22/201610:44:00Valeant Names Zoetis Executive as Financial Chief--Update
08/22/201607:30:00Valeant Names Zoetis Executive as CFO
08/22/201607:10:00Valeant Names Zoetis Executive as CFO
08/22/201606:00:00Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive...
08/22/201606:00:00Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive...
08/22/201603:03:00Valeant to Tap New CFO, As Shake-Up Continues -- WSJ
08/21/201622:10:00Valeant Hiring Paul Herendeen as New CFO
08/19/201603:04:00Valeant Makes Deal To Loosen Debt Terms -- WSJ
08/18/201616:29:00Valeant Again Able to Loosen Debt Terms -- 6th Update
08/18/201614:43:00Valeant Again Able to Loosen Debt Terms -- 5th Update

Valeant Pharma and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2015 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad